<DOC>
	<DOCNO>NCT01506050</DOCNO>
	<brief_summary>This open label , randomise , single dose , 2-way crossover , comparative bioequivalence study .</brief_summary>
	<brief_title>Bioequivalence Study Desloratadine OD Tablets 5 mg Under Fasting Condition</brief_title>
	<detailed_description>The objective study compare rate extent absorption Dr. Reddy 's Laboratories Ltd. , India , desloratadine ODT 5 mg Schering Corporation , U.S.A. ( ClarinexÂ® 5 mg ) , desloratadine ODT 5 mg fasting condition . The treatment phase separate washout period 14 day . 38 subject dose enrolled study ; 35 enrol subject complete study .</detailed_description>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>Is individual healthy , normal adult man woman volunteer participate ? Is s/he within 18 45 year age , inclusive ? Is his/her BMI 19 30 inclusive ? Is willing avoid pregnancy abstain sexual intercourse nonsterile male partner , use one follow method : diaphragm + spermicide condom + spermicide ( least 14 day dose ) , intrauterine contraceptive device hormonal contraceptive ( least 4 week prior dose ) surgically sterile postmenopausal least six month prior enter study ? Is s/he consider reliable capable understand his/her responsibility role study ? Has s/he provide write informed consent ? Does individual history allergy hypersensitivity desloratadine ? Does s/he clinically significant laboratory abnormality would interfere conduct interpretation study jeopardize his/her safety ? Does s/he significant history clinical evidence autoimmune , cardiovascular , gastrointestinal , hematological , hematopoietic , hepatic , neurological , ongoing infection , pancreatic , renal disease would interfere conduct interpretation study jeopardize his/her safety ? Is nurse ? Does s/he serious psychological illness ? Does s/he significant history ( within past year ) clinical evidence alcohol drug abuse ? Does s/he positive urine drug screen positive HIVI , hepatitis B C screen , positive pregnancy test ? Is s/he unable refrain use alcohol xanthinecontaining food beverage period begin 48 hour prior study drug administration end last blood sample take study period ? Has s/he use prescription drug , hormonal contraceptive , 14 day period prior study initiation , OTC drug 72 hour period precede study initiation ? Is s/he unable refrain use concomitant medication , hormonal contraceptive , study ? Has s/he donate lose blood participate clinical study involve withdrawal large volume blood ( 480 mL ) , six week period precede study initiation ? Has s/he donate plasma two week period precede study initiation ? Has s/he receive investigational drug 30 day period precede study initiate ? Has s/he use tobacco product 3 month precede drug administration ?</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Desloratadine</keyword>
	<keyword>crossover</keyword>
</DOC>